Anthropic Unleashes Claude Science: AI Workbench Supercharges Scientific Discovery and Drug Hunt

Anthropic has officially launched Claude Science, an AI-powered 'workbench' designed to drastically accelerate scientific discovery, particularly in drug research. This new application integrates over 60 scientific databases, coding tools, and high-performance computing resources into a single, unified environment, aiming to free scientists from tedious data management tasks and boost their focus on critical analysis and innovation. Early beta users have reported a tenfold acceleration in complex analyses, marking a significant leap for AI in the lab. The move comes as major tech players like Anthropic, OpenAI, and Google are locked in a race to dominate the life sciences sector with specialized AI tools. Just weeks ago, the US government relaxed an export ban on Anthropic advanced AI models, including Mythos and Claude Fable 5, after the company implemented enhanced safety measures amidst concerns over their potential misuse. Claude Science, running on these powerful underlying models, is positioned to rival offerings like OpenAI GPT-Rosalind and Google's Gemini for Science, highlighting the intense competition to revolutionize scientific workflows and drug development. Looking ahead, Anthropic is not just providing tools but is also venturing into its own internal drug discovery program focused on neglected diseases, using Claude Science to build firsthand experience. The platform is currently available in beta for existing Claude users on macOS and Linux, with Anthropic offering up to $30,000 in credits for scientific projects. This dual approach of developing both a powerful research platform and using it for their own discoveries could set a new precedent for AI companies in the scientific frontier, demanding close observation from the global research community.